• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物丰度增加和减少与帕金森病的关联:系统评价和亚组荟萃分析。

Association between increased and decreased gut microbiota abundance and Parkinson's disease: A systematic review and subgroup meta-analysis.

机构信息

Department of Neurology, Jinqiu Hospital of Liaoning Province, Shenyang 110016, China.

Key Lab of Environmental Pollution and Microecology of Liaoning Province, Shenyang Medical College, Shenyang 110034, China.

出版信息

Exp Gerontol. 2024 Jun 15;191:112444. doi: 10.1016/j.exger.2024.112444. Epub 2024 Apr 29.

DOI:10.1016/j.exger.2024.112444
PMID:38679353
Abstract

OBJECTIVE

The objective of the study was to systematically investigate the association between gut microbiota (GM) abundance and Parkinson's disease (PD).

METHODS

PubMed, Medline, Cochrane Library and other literature datebase platforms were searched for eligible studies in the English-language from conception to March 1, 2024. Studies evaluating the association between GM and PD were included. The results of the included studies were analyzed using a random effects model with calculation of the mean difference (MD) with the 95 % confidence interval to quantify the incidence of differences in abundance of various bacterial families in PD patients. Continuous models were used to analyze the extracted data.

RESULTS

A total of 14 studies with 1045 PD cases and 821 healthy controls were included for data extraction and meta-analysis. All the included studies exhibited reasonable quality. The included studies reported the data on the ratios of 10 families of GM. Of these 10 microbiota families, Bifidobacteriaceae, Ruminococcaceae, Rikenellaceae, Lactobacillaceae, Verrucomicrobiaceae and Christensenellaceae were found to have increased ratios according to the pooled ratios, while Prevotellaceae, Lachnospiraceae, Erysipelotrichaceae and Faecalibacterium were decreased in PD cases.

CONCLUSION

Patients in the PD cohort exhibited distinctive microbiota compositions compared to healthy individuals, with unique differential patterns in gut microbiome abundance at the phylum, family, and genus levels that may be associated wtih PD pathogenesis.

摘要

目的

本研究旨在系统研究肠道微生物群(GM)丰度与帕金森病(PD)之间的关联。

方法

检索 PubMed、Medline、Cochrane Library 及其他文献数据库平台,检索从概念提出到 2024 年 3 月 1 日的英文文献,纳入评估 GM 与 PD 之间关联的研究。采用随机效应模型对纳入研究的结果进行分析,计算各种细菌家族丰度差异的均数差(MD)及其 95%置信区间,以量化 PD 患者中各种细菌家族丰度差异的发生率。采用连续模型分析提取的数据。

结果

共纳入 14 项研究,包括 1045 例 PD 病例和 821 例健康对照者,用于提取和荟萃分析数据。所有纳入的研究均显示出合理的质量。纳入的研究报告了 GM 的 10 个家族的比值数据。在这 10 个微生物家族中,双歧杆菌科、瘤胃球菌科、真杆菌科、乳杆菌科、疣微菌科和克里斯滕森菌科的比例根据汇总比值显示出增加,而拟杆菌科、普雷沃氏菌科、肠杆菌科和粪杆菌科在 PD 病例中减少。

结论

与健康个体相比,PD 队列患者表现出独特的微生物群落组成,在门、科和属水平的肠道微生物组丰度存在独特的差异模式,这可能与 PD 的发病机制有关。

相似文献

1
Association between increased and decreased gut microbiota abundance and Parkinson's disease: A systematic review and subgroup meta-analysis.肠道微生物丰度增加和减少与帕金森病的关联:系统评价和亚组荟萃分析。
Exp Gerontol. 2024 Jun 15;191:112444. doi: 10.1016/j.exger.2024.112444. Epub 2024 Apr 29.
2
Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.神经退行性疾病(帕金森病和阿尔茨海默病)患者与健康对照者的肠道微生物组成:系统评价。
Nutrients. 2023 Oct 13;15(20):4365. doi: 10.3390/nu15204365.
3
Alterations of fecal microbiota and plasma metabolome in patients with Parkinson's disease with rapid eye movement sleep disorder.伴有快速眼动睡眠障碍的帕金森病患者粪便微生物群和血浆代谢组的改变
mSphere. 2025 Jun 25;10(6):e0059024. doi: 10.1128/msphere.00590-24. Epub 2025 May 9.
4
Gut bacterial profiles in Parkinson's disease: A systematic review.帕金森病的肠道细菌特征:系统评价。
CNS Neurosci Ther. 2023 Jan;29(1):140-157. doi: 10.1111/cns.13990. Epub 2022 Oct 25.
5
The impact of dietary patterns on gut microbiota for the primary and secondary prevention of cardiovascular disease: a systematic review.饮食模式对心血管疾病一级和二级预防中肠道微生物群的影响:一项系统评价
Nutr J. 2025 Jan 28;24(1):17. doi: 10.1186/s12937-024-01060-x.
6
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years.基于肠道微生物群的干预措施用于管理19岁及以下儿童和青少年的肥胖问题。
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015875. doi: 10.1002/14651858.CD015875.
7
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.肠道生物标志物、微生物群组成以及炎症性肠病的遗传易感性作为帕金森病表现的预测指标。
J Parkinsons Dis. 2025 May 7:1877718X251328567. doi: 10.1177/1877718X251328567.
8
Gut Microbiome Characteristics in IgA Nephropathy: Qualitative and Quantitative Analysis from Observational Studies.IgA 肾病的肠道微生物组特征:观察性研究的定性和定量分析。
Front Cell Infect Microbiol. 2022 May 17;12:904401. doi: 10.3389/fcimb.2022.904401. eCollection 2022.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Alterations of gut microbiota biodiversity and relative abundance in women with PCOS: A systematic review and meta-analysis.多囊卵巢综合征患者肠道微生物多样性和相对丰度的改变:系统评价和荟萃分析。
Microb Pathog. 2023 Nov;184:106370. doi: 10.1016/j.micpath.2023.106370. Epub 2023 Sep 21.

引用本文的文献

1
Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson's disease treatment.针灸调节微生物群-肠-脑轴:一种治疗帕金森病的新策略。
Front Aging Neurosci. 2025 Aug 7;17:1640389. doi: 10.3389/fnagi.2025.1640389. eCollection 2025.
2
Microbial diversity in drug-naïve Parkinson's disease patients.未服用过药物的帕金森病患者的微生物多样性。
PLoS One. 2025 Aug 18;20(8):e0328761. doi: 10.1371/journal.pone.0328761. eCollection 2025.
3
The Small Intestinal Microbiota and the Gut-Brain Axis in Parkinson's Disease: A Narrative Review.
帕金森病中的小肠微生物群与肠-脑轴:一篇叙述性综述
Biomedicines. 2025 Jul 19;13(7):1769. doi: 10.3390/biomedicines13071769.
4
Metagenomics and transcriptomics analysis of aspartame's impact on gut microbiota and glioblastoma progression in a mouse model.阿斯巴甜对小鼠模型肠道微生物群和胶质母细胞瘤进展影响的宏基因组学和转录组学分析
Sci Rep. 2025 Jul 2;15(1):23298. doi: 10.1038/s41598-025-06193-5.
5
Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic Horizons.解读肠道-器官轴中的氧化三甲胺:从生物标志物、细胞死亡机制到治疗前景
Drug Des Devel Ther. 2025 Apr 29;19:3363-3393. doi: 10.2147/DDDT.S512207. eCollection 2025.
6
The Role of the Gastrointestinal Microbiota in Parkinson's Disease.胃肠道微生物群在帕金森病中的作用
Biomolecules. 2024 Dec 28;15(1):26. doi: 10.3390/biom15010026.
7
Pediatric migraine is characterized by traits of ecological and metabolic dysbiosis and inflammation.儿科偏头痛的特征是生态和代谢失调以及炎症的特征。
J Headache Pain. 2024 Oct 9;25(1):171. doi: 10.1186/s10194-024-01871-7.
8
Exploring Fecal Microbiota Transplantation for Modulating Inflammation in Parkinson's Disease: A Review of Inflammatory Markers and Potential Effects.探索粪菌移植调节帕金森病炎症的作用:炎症标志物及潜在影响的综述。
Int J Mol Sci. 2024 Jul 15;25(14):7741. doi: 10.3390/ijms25147741.